Inhibiting key metabolic enzyme shows promise against melanoma by Staff September 1, 2022 September 1, 2022 0 views 0Researchers have shown that inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth. The findings could lead to a new class of drugs to selectively treat melanoma, the most severe form of skin cancer.Source: sciencedaily.com ScienceDaily 0 FacebookTwitterPinterestEmail previous post Review suggests ‘parent-centred’ approach to medical imaging can enhance emotional connection to the unborn baby during pregnancy next post The impact of megafires on estuaries from Australia’s ‘Black Summer’ Related Posts Better medical record-keeping needed to fight antibiotic overuse May 17, 2024 Global life expectancy to increase by nearly 5... May 17, 2024 Modern plant enzyme partners with surprisingly ancient protein May 17, 2024 Sweet taste receptor affects how glucose is handled... May 17, 2024 How heatwaves are affecting Arctic phytoplankton May 17, 2024 Repeat COVID-19 vaccinations elicit antibodies that neutralize variants,... May 17, 2024